What are the common but costly conditions treated at hospitals?
Knowing what conditions are the most prevalent and costly in hospitals can help determine the focus of future research, which can ensure better care. A report sheds some light.
In a hospital setting, awareness of medical conditions that are most prevalent, have the highest costs, or greatest variations in costs can be helpful in determining which could most benefit from research funding. A report in JAMA Network Open gives necessary insight.1
Investigators performed a retrospective cohort study of children who had hospital encounters at 45 tertiary care US children’s hospitals. The Pediatric Clinical Classification System was used to classify the primary diagnosis discharge code. The Cost Master Index was used to determine the standard cost of hospital goods and services used for care, in order to eliminate the high variation in those costs across hospitals.
There were 2,882,490 inpatient hospital encounters included in the report. From a list of 50 most prevalent and 50 most costly conditions, there were 74 total conditions, of which 49 (66.2%) were medical, 15 (20.3%) were surgical, and 10 (13.5%) were medical/surgical. The top 10 costly conditions made up $12.4 billon of $33.4 billon total costs and 33.8% of all of the conditions. The highest cost per encounter was seen with extreme immaturity conditions (ie, birth weight 500-749 g) at $382,910 (95% CI, $368,084-$397,736). The highest degree of interhospital variability in cost was seen with major depressive disorder, type 1 diabetes with complications, diabetic ketoacidosis, and acute appendicitis without peritonitis. Conditions that had high prevalence, variation in cost, and overall cost were major depressive disorder (cost rank, 19; prevalence rank, 10), scoliosis (cost rank, 6; prevalence rank, 38), acute appendicitis with peritonitis (cost rank, 13; prevalence rank, 11), asthma (cost rank, 10; prevalence rank, 2), and dehydration (cost rank, 24; prevalence rank, 8).
Those in charge of determining where to allocate research funding for improved care and outcomes should keep in mind the conditions that were found to be most common and costly.
Reference
1. Gill P, Anwar M, Thavam T, et al. Identifying conditions with high prevalence, cost, and variation in cost in US children’s hospitals. JAMA Netw Open. 2021;4(7):e2117816. doi:10.1001/jamanetworkopen.2021.17816
Fluoxetine helps refractory nocturnal enuresis but not for long
March 29th 2023A 12-week study in Egypt of the efficacy of fluoxetine (a selective serotonin reuptake inhibitor) in children with treatment-refractory nocturnal enuresis (NE) found that though the treatment achieved a good initial response, it was not sustainable.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Are some patients predisposed to avascular necrosis after hip surgery?
March 14th 2023Although avascular necrosis (AVN) is believed to be an iatrogenic complication following treatment of developmental dysplasia of the hip, an investigation in China found 2 characteristics associated with the condition: the likelihood of AVN increases with both the grade of dislocation and of underdevelopment of the ossific nucleus.
Meet the board: Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
April 22nd 2022In the latest episode of our podcast series, Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN shares why she got into medicine, the myths of pediatric, and what the future may hold for the specialty.
